Related Experiment Video
Updated: Aug 20, 2026
Disposable Dosators Intended for Dry Powder Delivery to Mice
Published on: August 18, 2023
Design of aerosolized amphotericin b formulations for prophylaxis trials among lung transplant recipients
John R Perfect1, Elizabeth Dodds Ashley, Richard Drew
1Division of Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA. Perfe001@mc.duke.edu
Background:
Emphasis has been placed on the need for antifungal prophylaxis when transplanted organs are directly exposed to the environment. In lung transplantation, one strategy for prevention has been aerosolization of polyenes into the lung. Despite widespread use of amphotericin B aerosols, there are still few studies on how to validate their effectiveness or optimize pharmacokinetics.
Methods:
We compared results of several of our own studies of lung transplant recipients receiving formulations of amphotericin B with results of other studies.
Results:
Recent aerosol studies suggest that aerosols of a lipid formulation of amphotericin B are safe and better tolerated than is amphotericin B deoxycholate. Their use in prophylaxis is associated with very few pulmonary fungal infections.
Conclusion:
This safe drug delivery at a local body site to directly protect the transplanted organ without systemic antifungal drug exposure is attractive from a cost and toxicity standpoint. However, careful multicenter, comparative studies are still needed to ensure that this strategy is consistently successful.
Insights
Aerosolized lipid formulations of amphotericin B are safe and effective for preventing fungal infections in lung transplant recipients. Further multicenter studies are needed to confirm optimal use and consistent success.
Area of Science:
- Medical Mycology
- Transplantation Immunology
- Pharmacokinetics
Background:
- Antifungal prophylaxis is crucial for transplanted organs exposed to the environment.
- Aerosolized polyenes are used for prevention in lung transplantation.
- Limited data exist on validating amphotericin B aerosol effectiveness and pharmacokinetics.
Purpose of the Study:
- To evaluate the safety and efficacy of aerosolized amphotericin B formulations in lung transplant recipients.
- To compare different amphotericin B formulations for pulmonary antifungal prophylaxis.
Main Methods:
- Comparative analysis of existing studies on lung transplant recipients receiving amphotericin B aerosols.
- Review of studies investigating lipid formulations versus amphotericin B deoxycholate.
Main Results:
- Lipid formulations of amphotericin B aerosols are safe and well-tolerated.
- These formulations are associated with a low incidence of pulmonary fungal infections.
- Lipid formulations appear superior to amphotericin B deoxycholate in tolerability.
Conclusions:
- Local drug delivery via aerosols protects transplanted lungs without systemic exposure, offering cost and toxicity benefits.
- This approach is promising for preventing fungal infections post-lung transplant.
- Multicenter, comparative studies are essential to establish consistent success and optimize this prophylactic strategy.
